193 related articles for article (PubMed ID: 15304981)
21. Interest of designed cyclodextrin-tools in gene delivery.
Duval RE; Clarot I; Dumarcay-Charbonnier F; Fontanay S; Marsura A
Ann Pharm Fr; 2012 Nov; 70(6):360-9. PubMed ID: 23177563
[TBL] [Abstract][Full Text] [Related]
22. Effects of cyclodextrins on drug delivery through biological membranes.
Loftsson T; Vogensen SB; Brewster ME; Konrádsdóttir F
J Pharm Sci; 2007 Oct; 96(10):2532-46. PubMed ID: 17630644
[TBL] [Abstract][Full Text] [Related]
23. Improvement of oral bioavailability of fenbufen by cyclodextrin complexations.
Miyaji T; Inoue Y; Acartürk F; Imai T; Otagiri M; Uekama K
Acta Pharm Nord; 1992; 4(1):17-22. PubMed ID: 1515048
[TBL] [Abstract][Full Text] [Related]
24. [Interactions between cyclodextrins and triglycerides: from emulsion stabilisation to the emergence of a new drug delivery system called "beads"].
Hamoudi M; Trichard L; Grossiord JL; Chaminade P; Duchêne D; Le Bas G; Fattal E; Bochot A
Ann Pharm Fr; 2009 Nov; 67(6):391-8. PubMed ID: 19900602
[TBL] [Abstract][Full Text] [Related]
25. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
Uekama K; Minami K; Hirayama F
J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
[TBL] [Abstract][Full Text] [Related]
26. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
Loftsson T; Brewster ME
J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
[TBL] [Abstract][Full Text] [Related]
27. Design and Evaluation of the Highly Concentrated Human IgG Formulation Using Cyclodextrin Polypseudorotaxane Hydrogels.
Higashi T; Tajima A; Ohshita N; Hirotsu T; Abu Hashim II; Motoyama K; Koyama S; Iibuchi R; Mieda S; Handa K; Kimoto T; Arima H
AAPS PharmSciTech; 2015 Dec; 16(6):1290-8. PubMed ID: 25776984
[TBL] [Abstract][Full Text] [Related]
28. Model predicting impact of complexation with cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2013 Sep; 110(9):2536-47. PubMed ID: 23592239
[TBL] [Abstract][Full Text] [Related]
29. Design and evaluation of polypseudorotaxanes of pegylated insulin with cyclodextrins as sustained release system.
Higashi T; Hirayama F; Misumi S; Arima H; Uekama K
Biomaterials; 2008 Oct; 29(28):3866-71. PubMed ID: 18620750
[TBL] [Abstract][Full Text] [Related]
30. Cyclodextrins: application in different routes of drug administration.
Shimpi S; Chauhan B; Shimpi P
Acta Pharm; 2005 Jun; 55(2):139-56. PubMed ID: 16179128
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
Loftsson T; Brewster ME
J Pharm Pharmacol; 2011 Sep; 63(9):1119-35. PubMed ID: 21827484
[TBL] [Abstract][Full Text] [Related]
32. Amphiphilic cyclodextrin nanoparticles.
Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
[TBL] [Abstract][Full Text] [Related]
33. Polypseudorotaxanes of pegylated α-cyclodextrin/polyamidoamine dendrimer conjugate with cyclodextrins as a sustained release system for DNA.
Motoyama K; Hayashida K; Higashi T; Arima H
Bioorg Med Chem; 2012 Feb; 20(4):1425-33. PubMed ID: 22277591
[TBL] [Abstract][Full Text] [Related]
34. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
Minami K; Hirayama F; Uekama K
J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
[TBL] [Abstract][Full Text] [Related]
35. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
[TBL] [Abstract][Full Text] [Related]
36. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
[TBL] [Abstract][Full Text] [Related]
37. Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs.
Chen J; Lu WL; Gu W; Lu SS; Chen ZP; Cai BC; Yang XX
Expert Opin Drug Deliv; 2014 Apr; 11(4):565-77. PubMed ID: 24490763
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin.
Pápay ZE; Sebestyén Z; Ludányi K; Kállai N; Balogh E; Kósa A; Somavarapu S; Böddi B; Antal I
J Pharm Biomed Anal; 2016 Jan; 117():210-6. PubMed ID: 26363816
[TBL] [Abstract][Full Text] [Related]
39. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
[TBL] [Abstract][Full Text] [Related]
40. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
